Filing Details

Accession Number:
0001055947-12-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-02 18:36:53
Reporting Period:
2012-10-26
Filing Date:
2012-11-02
Accepted Time:
2012-11-02 18:36:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
918923 P L Fund Value Biotechnology 900 N. Michigan Ave., Suite 1100
Chicago IL 60611
No No No Yes
1055947 P/Il L Partners Bvf 900 N. Michigan Ave., Suite 1100
Chicago IL 60611
No No Yes No
1056807 Bvf Inc/Il 900 N. Michigan Ave., Suite 1100
Chicago IL 60611
No No Yes No
1233840 N Mark Lampert 900 N. Michigan Ave., Suite 1100
Chicago IL 60611
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-10-26 12,515 $15.26 737,551 No 4 P Indirect See Explanation of Responses
Common Stock Acquisiton 2012-10-31 4,076 $14.99 741,627 No 4 P Indirect See Explanation of Responses
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Explanation of Responses
No 4 P Indirect See Explanation of Responses
Footnotes
  1. This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), BVF Partners L.P. ("Partners"), BVF Inc., and Mark Lampert (collectively the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a section 13G group that collectively owns more than 10% of the Issuer's oustanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.
  2. Represents shares of Common Stock owned directly by BVF. As the general partner of BVF, Partners may be deemed to beneficially own the shares of Common Stock owned directly by BVF. As the investment adviser and general partner of Partners, BVF Inc., may be deemed to beneficially own the shares of Common Stock owned directly by BVF. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the shares of Common Stock owned directly by BVF.
  3. Units may represent aggregation of daily trade activity. Details regarding individual execution amounts and prices are available upon request